509 related articles for article (PubMed ID: 9162299)
1. Evaluation of proliferating cell nuclear antigen as a surrogate end point biomarker in actinic keratosis and adjacent, normal-appearing, and non-sun-exposed human skin samples.
Einspahr J; Alberts DS; Aickin M; Welch K; Bozzo P; Levine N; Grogan T
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):343-8. PubMed ID: 9162299
[TBL] [Abstract][Full Text] [Related]
2. Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin.
Einspahr J; Alberts DS; Aickin M; Welch K; Bozzo P; Grogan T; Nelson M
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):583-7. PubMed ID: 9264270
[TBL] [Abstract][Full Text] [Related]
3. Reproducibility and expression of skin biomarkers in sun-damaged skin and actinic keratoses.
Einspahr JG; Xu MJ; Warneke J; Saboda K; Ranger-Moore J; Bozzo P; Duckett L; Goldman R; Lin P; Buckmeier J; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1841-8. PubMed ID: 17021352
[TBL] [Abstract][Full Text] [Related]
4. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
[TBL] [Abstract][Full Text] [Related]
6. Modulation of biologic endpoints by topical difluoromethylornithine (DFMO), in subjects at high-risk for nonmelanoma skin cancer.
Einspahr JG; Nelson MA; Saboda K; Warneke J; Bowden GT; Alberts DS
Clin Cancer Res; 2002 Jan; 8(1):149-55. PubMed ID: 11801552
[TBL] [Abstract][Full Text] [Related]
7. Clinical recognition of actinic keratoses in a high-risk population: how good are we?
Venna SS; Lee D; Stadecker MJ; Rogers GS
Arch Dermatol; 2005 Apr; 141(4):507-9. PubMed ID: 15837871
[TBL] [Abstract][Full Text] [Related]
8. Nuclear morphometry and molecular biomarkers of actinic keratosis, sun-damaged, and nonexposed skin.
Carpenter PM; Linden KG; McLaren CE; Li KT; Arain S; Barr RJ; Hite P; Sun JD; Meyskens FL
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):1996-2002. PubMed ID: 15598753
[TBL] [Abstract][Full Text] [Related]
9. Facial resurfacing for nonmelanoma skin cancer prophylaxis.
Hantash BM; Stewart DB; Cooper ZA; Rehmus WE; Koch RJ; Swetter SM
Arch Dermatol; 2006 Aug; 142(8):976-82. PubMed ID: 16924046
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors.
Iftner A; Klug SJ; Garbe C; Blum A; Stancu A; Wilczynski SP; Iftner T
Cancer Res; 2003 Nov; 63(21):7515-9. PubMed ID: 14612553
[TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen (PCNA) and p53 in epithelial dysplasia and squamous cell carcinoma of oral mucosa--a marker for poor tumor differentiation, increasing nuclear atypia and invasiveness?
Lan HA; Zain RB; Saitoh M; Muramatsu Y; Shrestha P; Mori M
Anticancer Res; 1996; 16(5B):3059-65. PubMed ID: 8920767
[TBL] [Abstract][Full Text] [Related]
12. Expression of p53 in the evolution of squamous cell carcinoma: correlation with the histology of the lesion.
Barzilai A; Lyakhovitsky A; Trau H; Fogel M; Huszar M
J Am Acad Dermatol; 2007 Oct; 57(4):669-76. PubMed ID: 17870432
[TBL] [Abstract][Full Text] [Related]
13. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
[TBL] [Abstract][Full Text] [Related]
14. Actinic keratosis is squamous cell carcinoma.
Lober BA; Lober CW
South Med J; 2000 Jul; 93(7):650-5. PubMed ID: 10923948
[TBL] [Abstract][Full Text] [Related]
15. Modulation of proliferating cell nuclear antigen in the bronchial epithelium of smokers.
Khuri FR; Lee JS; Lippman SM; Lee JJ; Kalapurakal S; Yu R; Ro JY; Morice RC; Hong WK; Hittelman WN
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):311-8. PubMed ID: 11319170
[TBL] [Abstract][Full Text] [Related]
16. Actinic keratoses: non-invasive diagnosis for field cancerisation.
Ulrich M; Maltusch A; Röwert-Huber J; González S; Sterry W; Stockfleth E; Astner S
Br J Dermatol; 2007 May; 156 Suppl 3():13-7. PubMed ID: 17488401
[TBL] [Abstract][Full Text] [Related]
17. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
Criscione VD; Weinstock MA; Naylor MF; Luque C; Eide MJ; Bingham SF;
Cancer; 2009 Jun; 115(11):2523-30. PubMed ID: 19382202
[TBL] [Abstract][Full Text] [Related]
18. Chemokine receptor expression in non-melanoma skin cancer.
Basile J; Thiers B; Maize J; Lathers DM
J Cutan Pathol; 2008 Jul; 35(7):623-9. PubMed ID: 18312436
[TBL] [Abstract][Full Text] [Related]
19. Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression.
Padilla RS; Sebastian S; Jiang Z; Nindl I; Larson R
Arch Dermatol; 2010 Mar; 146(3):288-93. PubMed ID: 20231500
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin.
Hodges A; Smoller BR
Mod Pathol; 2002 Nov; 15(11):1121-5. PubMed ID: 12429789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
